Amgen's Participation at the Jefferies Global Healthcare Conference
Amgen (NASDAQ: AMGN) is preparing to showcase its advancements at the Jefferies Global Healthcare Conference, scheduled for June 4, 2025. The presentation will take place at 9:20 a.m. ET and will feature key figures, including Peter Griffith, who serves as the executive vice president and chief financial officer of Amgen, alongside Murdo Gordon, the executive vice president of Global Commercial Operations. This event aims to provide insights into Amgen's commitment to innovation in healthcare.
Webcast Details and Accessibility
The presentation will be available via a live webcast, ensuring that members of the media, investors, and the general public can access the content online. This initiative reflects Amgen's ongoing dedication to transparency and communication with stakeholders. After the event, the archived webcast will be accessible for a minimum of 90 days, enabling a wider audience to benefit from the insights shared during the conference.
Amgen's Commitment to Innovation
Amgen has a rich history in discovering, developing, and delivering cutting-edge medicines to combat some of the toughest diseases facing patients today. With over 40 years of experience, Amgen continues to lead the biotechnology sector, leveraging technology and human genetics to foster progress beyond current limitations. Its ambitious pipeline is aimed at addressing multiple health conditions, including cancer, osteoporosis, heart disease, inflammatory diseases, and various rare disorders.
External Recognitions and Achievements
In 2024, Amgen earned accolades as one of the "World's Most Innovative Companies" awarded by Fast Company and was also recognized as one of "America's Best Large Employers" by Forbes. Such recognitions underscore Amgen's unwavering commitment to excellence and innovative practices within the healthcare industry.
Further Engagement Opportunities
For those interested in learning more about Amgen's latest developments and innovations, the company encourages visits to its official website. Relevant information regarding upcoming presentations, webcasts, and ongoing projects is readily available through Amgen's Investor Relations Events Calendar. Amgen's commitment to keeping its stakeholders informed is a priority as it navigates through the complexities of biotechnology.
Stay Updated with Amgen
In addition to their website, Amgen fosters engagement through social media platforms including X, LinkedIn, Instagram, YouTube, and Threads. By following these channels, stakeholders can receive real-time updates on Amgen's latest news, research, and initiatives designed to improve patient outcomes globally.
Frequently Asked Questions
What is the Jefferies Global Healthcare Conference?
The Jefferies Global Healthcare Conference is an important event where leading companies present updates and insights into their healthcare strategies and innovations.
Who will represent Amgen at the conference?
Peter Griffith and Murdo Gordon are scheduled to present Amgen's strategies and advancements during the event.
How can I access the presentation by Amgen?
The presentation will be accessible through a live webcast on Amgen's official site and archived for later viewing for at least 90 days.
What areas does Amgen focus on?
Amgen focuses on the development of medicines for conditions such as cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases.
Where can I find more information about Amgen?
For further information about Amgen, visit their official website and follow their social media accounts for the latest updates.
